Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registry-Reference-Cited by-同舟云学术

Evaluation of the SAMe-TT2R2 score to predict the quality of anticoagulation control in patients with venous thromboembolism treated with vitamin K antagonists: Findings from the RIETE registry

Published:2020-10 Issue: Volume:194 Page:178-182
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

del-Toro-Cervera Jorge,Demelo-Rodriguez Pablo,Galeano-Valle Francisco,Fidalgo Ángeles,Sampériz Ángel,Muñoz-Torrero Juan Francisco Sánchez,Lima Jorge,Sigüenza Patricia,Tufano Antonella,Monreal Manuel

Funder

Sanofi Spain

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality;Cohen;Thromb. Haemost.,2007

2. Venous thromboembolism in Spain. Comparison between an administrative database and the RIETE registry;Guijarro;Eur J Intern Med.,2008

3. Update on extended treatment for venous thromboembolism;Peñaloza-Martínez;Ann. Med.,2018

4. Venous thromboembolism: a public health concern;Beckman;Am. J. Prev. Med.,2010

5. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis;Kearon,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SAMe-TT2R2 Score to Predict Time in Therapeutic Range of Vitamin K Antagonists in Asian and Non-Asian patients: A Systematic Review and Meta-analysis;American Journal of Cardiovascular Drugs;2024-01-22

2. SAMe-TT₂R₂ to Predict Clinical Outcomes and Time in Therapeutic Range in Patients on Vitamin K Antagonists: A Systematic Review and Meta-Analysis;Annals of Pharmacotherapy;2023-04-26

3. Effect of current smoking on ischemic events in patients with atrial fibrillation taking vitamin K antagonist;International Journal of Cardiology Cardiovascular Risk and Prevention;2022-09

4. The influence of clinical and genetic factors on the stability of warfarin’s anticoagulant effect in patients with atrial fibrillation;Pathologia;2022-04-15